Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Schizophrenia
Recent news which mentions Schizophrenia
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
Schizophrenia
Psychedelics
MDMA/assisted therapy
From
Benzinga
Psychedelics And Schizophrenia: What's The Link?
February 19, 2023
Tags
Schizophrenia
contributors
Benzinga
From
Benzinga
Tips on Managing Your Schizophrenia
August 22, 2022
Tickers
ALKS
Tags
NASDAQ:ALKS
NAMI
Alkermes
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Marketing & Marijuana: Why Responsibility Is So Important As Psychosis & Schizophrenia Among Youth Rise
June 08, 2022
Tickers
CBD
CURLF
Tags
General
Schizophrenia
Leafreport
From
Benzinga
Addex Expands Pipeline With Selective M4 PAM Program For Schizophrenia & Other Psychotic Disorders
April 06, 2022
Tickers
ADXN
Tags
Biotech
Benzinga
Briefs
From
Benzinga
Amid Russia's Invasion On Ukraine, Karuna Therapeutics Withdraws Guidance On Late-Stage Schizophrenia Trial
February 24, 2022
Tickers
KRTX
Tags
Schizophrenia
KRTX
Benzinga
From
Benzinga
Cannabis Increases Odds Of This Disorder In Teens Despite Infrequent Use
February 08, 2022
Tags
Market News
contributors
Cannabis
From
Benzinga
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
February 08, 2022
Tickers
ALKS
Tags
Briefs
Schizophrenia
Benzinga
From
Benzinga
Alkermes Highlights Signs and Symptoms of Schizophrenia
January 31, 2022
Tags
National Institute of Mental Health
Schizophrenia
mental health
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Gives Green Signal To Reviva Pharma's Late-Stage Schizophrenia Trial
January 10, 2022
Tickers
RVPH
Tags
Market News
why it's moving
Health Care
From
Benzinga
FDA Pushes Review Of BioXcel's Candidate For Agitation Associated With Neuropsychiatric Disorders
December 01, 2021
Tickers
BTAI
Tags
Market News
Trading Ideas
Health Care
From
Benzinga
Neurocrine Pens $2.6B Pact With Sosei Heptares For Neuro Targets
November 22, 2021
Tickers
NBIX
Tags
Benzinga
Biotech
Briefs
From
Benzinga
ATAI Life's Schizophrenia Candidate Shows Promising Action In Mid-Stage Study
November 01, 2021
Tickers
ATAI
Tags
Trading Ideas
Health Care
News
From
Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
Tags
Schizophrenia
Briefs
Phase 3 Trial
From
Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
Tags
NERV
Schizophrenia
Briefs
From
Benzinga
Alkermes Announces Launch of 4th Annual Alkermes Pathways Research Awards® Program
September 13, 2021
Tickers
ALKS
Tags
Responsible Production & Consumption
opioid use disorder (OUD)
Sustainable Finance & Socially Responsible Investment
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves First And Only Twice-Yearly Schizophrenia Drug
September 01, 2021
Tickers
JNJ
Tags
News
Schizophrenia
Briefs
From
Benzinga
Teva-MedinCell's Schizophrenia Treatment Candidate Under FDA Review
September 01, 2021
Tickers
TEVA
Tags
Schizophrenia
Briefs
News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.